The purpose of this guideline is to assist nuclear medicine practitioners in evaluating patients who might be candidates for intra-articular treatment using colloidal preparations of 90Y, 186Re or 169Er, providing information regarding the performance of these treatments and understanding and evaluating the sequelae of therapy.
